(Q22306247)

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Testosterone hormone replacement therapy: state-of-the-art and emerging technologies

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Venous thromboembolism: epidemiology, characteristics, and consequences

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Testosterone replacement therapy for late-onset hypogonadism

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Validation of a screening questionnaire for androgen deficiency in aging males

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Risks of testosterone-replacement therapy and recommendations for monitoring

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Endogenous sex hormone levels in older adult men with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Hypoandrogen-metabolic syndrome: a potentially common and underdiagnosed condition in men

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Sex steroid hormones, upper body obesity, and insulin resistance.

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Endogenous sex hormones and metabolic syndrome in aging men.

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Contrasting testosterone concentrations in type 1 and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050.

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III)

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

1 reference

https://api.crossref.org/works/10.1177%2F0145721708323100

7 January 2021